Fidelity Investments’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Fidelity Investments’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-111	Closed	-$1K	–	4257
2020 Q1	$1K	Buy	+111	New	+$1.55K	﹤0.01%	3546
2019 Q1	–	Sell	-52	Closed	-$1K	–	4298
2018 Q4	$1K	Hold	52	–	–	﹤0.01%	3436
2018 Q3	$1K	Buy	+52	New	+$1.58K	﹤0.01%	3466
2018 Q2	–	Sell	-72,306	Closed	-$4.72M	–	2726
2018 Q1	$4.72M	Hold	72,306	–	–	﹤0.01%	2181
2017 Q4	$5.28M	Hold	72,306	–	–	﹤0.01%	2157
2017 Q3	$6.63M	Sell	72,306 -7,211	-9%	-$553K	﹤0.01%	2081
2017 Q2	$5.26M	Sell	79,517 -21,023	-21%	-$2.6M	﹤0.01%	2154
2017 Q1	$21.8M	Hold	100,540	–	–	﹤0.01%	1661
2016 Q4	$9.3M	Buy	100,540 +54,704	+119%	+$6.16M	﹤0.01%	2000
2016 Q3	$6.2M	Sell	45,836 -59,652	-57%	-$5.92M	﹤0.01%	2143
2016 Q2	$10.7M	Sell	105,488 -5,948	-5%	-$737K	﹤0.01%	1932
2016 Q1	$18.3M	Sell	111,436 -83,359	-43%	-$16.9M	﹤0.01%	1705
2015 Q4	$63.8M	Sell	194,795 -45,435	-19%	-$14.8M	0.01%	1165
2015 Q3	$77.5M	Buy	240,230 +748	+0.3%	+$329K	0.01%	1068
2015 Q2	$95.4M	Sell	239,482 -18,079	-7%	-$7.68M	0.01%	1059
2015 Q1	$127M	Sell	257,561 -5,033	-2%	-$1.95M	0.02%	924
2014 Q4	$93.9M	Sell	262,594 -127,431	-33%	-$37.9M	0.01%	1034
2014 Q3	$75.2M	Buy	390,025 +4,689	+1%	+$1.03M	0.01%	1105
2014 Q2	$92.1M	Sell	385,336 -20,696	-5%	-$4.21M	0.01%	1044
2014 Q1	$104M	Buy	406,032 +256,959	+172%	+$78.6M	0.01%	962
2013 Q4	$29.5M	Sell	149,073 -71,276	-32%	-$12.7M	﹤0.01%	1558
2013 Q3	$37.2M	Sell	220,349 -63,946	-22%	-$10.3M	0.01%	1422
2013 Q2	$50.5M	Buy	+284,295	New	+$40.3M	0.01%	1240

Other funds holding LUMO

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments's LUMO Position: Q2 2020 in Review

Fidelity Investments sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2020, closing a stake of 111 shares — an estimated $1K sold.

Fidelity Investments first reported a position in LUMO in Q2 2013 and held it in 23 quarters. The position peaked at $127M in Q1 2015. 43 funds tracked by Wall St. Rank hold LUMO as of Q2 2020.

Fidelity Investments reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Fidelity Investments sold 111 Lumos Pharma, Inc. Common Stock shares in Q2 2020, an estimated $1K.
Fidelity Investments first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
Fidelity Investments's Lumos Pharma, Inc. Common Stock position peaked at $127M in Q1 2015.
43 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2020.

Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.